Chapter 25 – Renal Protection in Chronic Kidney Disease

作者: Donna S. Hanes , Matthew R. Weir

DOI: 10.1016/B978-0-7216-0258-5.50115-0

关键词:

摘要:

参考文章(134)
M Epstein, J R Oster, Beta blockers and renal function: a reappraisal. Journal of Clinical Hypertension. ,vol. 1, pp. 85- 99 ,(1985)
John F. Moorhead, Lipids and the Pathogenesis of Kidney Disease Nephrology. ,vol. 17, pp. 165- 177 ,(1991) , 10.1007/978-3-662-35158-1_11
Lorenz Böhlen, Maximilian de Courten, Peter Weidmann, Comparative Study of the Effect of ACE-Inhibitors and Other Antihypertensive Agents on Proteinuria in Diabetic Patients American Journal of Hypertension. ,vol. 7, pp. 319- 332 ,(1994) , 10.1093/AJH/7.9.84S
Alberto Zanchetti, Kenneth Jamerson, Hans Wedel, Luis M. Ruilope, Antonio Salvetti, Lennart Hansson, Ingrid Warnold, Renal Function and Intensive Lowering of Blood Pressure in Hypertensive Participants of the Hypertension Optimal Treatment (HOT) Study Journal of The American Society of Nephrology. ,vol. 12, pp. 218- 225 ,(2001) , 10.1681/ASN.V122218
J R Diamond, N A Hanchak, M D McCarter, M J Karnovsky, Cholestyramine resin ameliorates chronic aminonucleoside nephrosis. The American Journal of Clinical Nutrition. ,vol. 51, pp. 606- 611 ,(1990) , 10.1093/AJCN/51.4.606